Skip to main content

Table 3 Number of interviewed respondents

From: Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysis

Stakeholder Argentina Brazil Chile Colombia Total
Executive(a) 2 1 0 5 8
Judiciary 3 3 0 2 8
Health system manager (b) (Manager) 6 3 2 2 13
Patient organization (Patient) 1 1 1 2 5
Health professional organization (Professional) 1 1 2 2 6
Other 5(c) 0 2(d) 3(e) 10
Total 18 9 7 16 50
  1. Source: The authors
  2. (a) Executive: Ministry of Health, medicines regulatory agency, superintendence of health or healthcare services;
  3. (b) Health system managers: State Health departments (Brazil), Obras Sociales (OSs) (Argetnina), Instituciones de Salud Previsional (ISAPREs) (Chile), Empresas Promotoras de Salud (EPSs) (Colombia)
  4. (c) NGOs, Senator’s advisor, Expert in pharmaceutical marketing, Expert in public policies of health
  5. (d) Lawyer involved in judicial cases for access to medicines, University lecturer expert in health economics
  6. (e) NGOs, University lecturer expert in litigation for health right